A unique psoriasis biologics clinic serving underprivileged patients in the United States  

Oleh:

Romanelli, Paolo ; Cavallin, Lucas E. ; Weiss, Jonathan ; Ricotti, Carlos ; Miteva, Mariya

Jenis: Article from Journal - ilmiah internasional
Dalam koleksi: JAAD: Journal of the American Academy of Dermatology (keterangan: ada di ClinicalKey) vol. 72 no. 01 (Jan. 2015), page 184–185 .
Topik: biologics; costs; indigent; psoriasis; systemic treatment

Ketersediaan

Perpustakaan FK Nomor Panggil: J15.K Non-tandon: tidak ada Tandon: 1

Lihat Detail Induk

Isi artikel

Psoriasis is the most prevalent autoimmune disease in the United States, affecting approximately 7.7 million people.1 As the economic impact of psoriasis correlates with the increased severity of the disease,2,3 it is of pivotal importance to provide patients who have psoriasis with comprehensive and continuous medical services. This is especially true for people with an underprivileged socioeconomic status as studies have suggested that these patients are more likely to have severe psoriasis and are less likely to be able to afford the most efficacious treatments, including costly biologic therapies.

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali